title: Orally administered amphotericin B in the treatment of oral candidiasis in HIV-infected patients caused by azole-resistant Candida albicans.
authors.forename: M T
authors.initials: MT
authors.lastname: Nguyen
authors.forename: P J
authors.initials: PJ
authors.lastname: Weiss
authors.forename: R C
authors.initials: RC
authors.lastname: LaBarre
authors.forename: L K
authors.initials: LK
authors.lastname: Miller
authors.forename: E C
authors.initials: EC
authors.lastname: Oldfield
authors.forename: M R
authors.initials: MR
authors.lastname: Wallace
mesh_terms: D017088:AIDS-Related Opportunistic Infections; D000284:Administration, Oral; D000666:Amphotericin B / Q000008:administration & dosage* / Q000494:pharmacology; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000494:pharmacology; D002177:Candidiasis / Q000188:drug therapy* / Q000209:etiology; D004352:Drug Resistance, Microbial; D015658:HIV Infections / Q000150:complications*; D015497:HIV-1; D006801:Humans; D009055:Mouth / Q000382:microbiology
chemical_list: D000935:Antifungal Agents; D000666:Amphotericin B